Schering-Plough, Merck Seek To Toss Vytorin Suit

Law360, New York (September 15, 2009, 4:44 PM EDT) -- Pharmaceutical giants Schering-Plough Corp. and Merck & Co. have asked a Texas court to dismiss a product liability case brought by a man who claims the companies did not warn him that the cholesterol drug Vytorin could cause his enzyme levels to spike.

The companies filed their motion to dismiss the entire case Sept. 14 in the U.S. District Court for the Eastern District of Texas, arguing that plaintiff James Acker had failed to state a claim.

Acker first filed the personal injury complaint in state...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Acker v. Schering-Plough Corporation et al


Case Number

1:09-cv-00824

Court

Texas Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Ron Clark

Date Filed

September 8, 2009

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.